Archaeal lipid vaccine adjuvants for induction of cell-mediated immunity

References

• Woese CR, Fox GE. Phylogenetic structure of the prokaryotic domain: the primary kingdoms. Proc Natl Acad Sci U S A. 1977;74:5088–5090.
   PubMed Web of Science ®Google Scholar
• Woese CR, Kandler O, Wheelis ML. Towards a natural system of organisms: proposal for the domains archaea, bacteria, and eucarya. Proc Natl Acad Sci U S A. 1990;87:4576–4579.
   PubMed Web of Science ®Google Scholar
• Spang A, Martijn J, Saw JH, et al. Close encounters of the third domain: the emerging genomic view of archaeal diversity and evolution. Archaea. 2013;2013:202358.
   PubMed Web of Science ®Google Scholar
• Madigan MT, Martinko JM, Parker J. Prokaryotic diversity: the archaea. In: Madigan MT, Martinko JM, Parker J, editors. Brock biology of microorganisms. Upper Saddle River (NJ): Prentice-Hall, Inc; 2000. p. 546–572.
   Google Scholar
• Alving CR, Peachman KK, Rao M, et al. Adjuvants for human vaccines. Curr Opin Immunol. 2012;24:310–315.
   PubMed Web of Science ®Google Scholar
• Allison AG, Gregoriadis G. Liposomes as immunological adjuvants. Nature. 1974;252:252.
   PubMed Web of Science ®Google Scholar
• Schwendener RA. Liposomes as vaccine delivery systems: a review of the recent advances. Ther Adv Vaccines. 2014;2:159–182.
   PubMedGoogle Scholar
• Ghaffar KA, Giddam AK, Zaman M, et al. Liposomes as nanovaccine delivery systems. Curr Top Med Chem. 2014;14:1194–1208.
   PubMed Web of Science ®Google Scholar
• Sharma A, Sharma U. Liposomes in drug delivery: progress and limitations. Int J Pharm. 1997;154:123–140.
   Web of Science ®Google Scholar
• Krishnan L, Sprott GD. Archaeosome adjuvants: immunological capabilities and mechanism(s) of action. Vaccine. 2008;26:2043–2055.
   PubMed Web of Science ®Google Scholar
• Brown DA, Venegas B, Cooke PH, et al. Bipolar tetraether archaeosomes exhibit unusual stability against autoclaving as studied by dynamic light scattering and electron microscopy. Chem Phys Lipids. 2009;159:95–103.
   PubMed Web of Science ®Google Scholar
• Mathai JC, Sprott GD, Zeidel ML. Molecular mechanisms of water and solute transport across archaebacterial lipid membranes. J Biol Chem. 2001;276:27266–27271.
   PubMed Web of Science ®Google Scholar
• Patel GB, Chen W. Archaeal lipid mucosal vaccine adjuvant and delivery system. Expert Rev Vaccines. 2010;9:431–440.
   PubMed Web of Science ®Google Scholar
• Krishnan L, Dicaire CJ, Patel GB, et al. Archaeosome vaccine adjuvants induce strong humoral, cell-mediated, and memory responses: comparison to conventional liposomes and alum. Infect Immun. 2000;68:54–63.
   PubMed Web of Science ®Google Scholar
• Tenchov B, Vescio EM, Sprott GD, et al. Salt tolerance of archaeal extremely halophilic lipid membranes. J Biol Chem. 2006;281:10016–10023.
   PubMed Web of Science ®Google Scholar
• Whitfield DM, Yu SH, Dicaire CJ, et al. Development of new glycosylation methodologies for the synthesis of archaeal-derived glycolipid adjuvants. Carbohydr Res. 2010;345:214–229.
   PubMed Web of Science ®Google Scholar
• Langworthy TA. Lipids of archaebacteria. In: Woese CR, Wolfe RS, editors. The bacteria. London (UK): Academic Press; 1985. p. 459–498.
   Google Scholar
• Sprott GD. Structures of archaebacterial membrane lipids. J Bioenerg Biomembr. 1992;24:555–566.
   PubMed Web of Science ®Google Scholar
• Comita PB, Gagosian RB, Pang H, et al. Structural elucidation of a unique macrocyclic membrane lipid from a new, extremely thermophilic, deep-sea hydrothermal vent archaebacterium, Methanococcus jannaschii. J Biol Chem. 1984;259:15234–15241.
   PubMed Web of Science ®Google Scholar
• Ferrante G, Brisson JR, Patel GB, et al. Structures of minor ether lipids isolated from the aceticlastic methanogen, Methanothrix concilii GP6. J Lipid Res. 1989;30:1601–1609.
   PubMed Web of Science ®Google Scholar
• Kates M. Structure, physical properties and function of archaebacterial lipids. In: Karnovsky M, Leaf A, Bolis L, editors. Biological membranes: aberrations in membrane structure and function. New York (NY): Alan R Liss; 1988. p. 357–384.
   Google Scholar
• Kates M. Glyco-, phosphoglyco- and sulfoglycoglycerolipids of bacteria. In: Kates M, editor. Handbook of lipid research. New York: Plenum Press; 1990. p. 1–122.
   Google Scholar
• Tolson DL, Latta RK, Patel GB, et al. Uptake of archaeobacterial liposomes and conventional liposomes by phagocytic cells. J Liposome Res. 1996;6:755–776.
   Google Scholar
• Sprott GD, Sad S, Fleming LP, et al. Archaeosomes varying in lipid composition differ in receptor-mediated endocytosis and differentially adjuvant immune responses to entrapped antigen. Archaea. 2003;1:151–164.
   PubMedGoogle Scholar
• Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol. 1996;14:233–258.
   PubMed Web of Science ®Google Scholar
• Krishnan L, Sad S, Patel GB, et al. The potent adjuvant activity of archaeosomes correlates to the recruitment and activation of macrophages and dendritic cells in vivo. J Immunol. 2001;166:1885–1893.
   PubMed Web of Science ®Google Scholar
• Gurnani K, Kennedy J, Sad S, et al. Phosphatidylserine receptor-mediated recognition of archaeosome adjuvant promotes endocytosis and MHC class I cross-presentation of the entrapped antigen by phagosome-to-cytosol transport and classical processing. J Immunol. 2004;173:566–578.
   PubMed Web of Science ®Google Scholar
• Fadok VA, Bratton DL, Konowal A, et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J Clin Invest. 1998;101:890–898.
   PubMed Web of Science ®Google Scholar
• Krishnan L, Sad S, Patel GB, et al. Archaeosomes induce enhanced cytotoxic T lymphocyte responses to entrapped soluble protein in the absence of interleukin 12 and protect against tumor challenge. Cancer Res. 2003;63:2526–2534.
   PubMed Web of Science ®Google Scholar
• Hoffmann PR, Kench JA, Vondracek A, et al. Interaction between phosphatidylserine and the phosphatidylserine receptor inhibits immune responses in vivo. J Immunol. 2005;174:1393–1404.
   PubMed Web of Science ®Google Scholar
• Somersan S, Bhardwaj N. Tethering and tickling: a new role for the phosphatidylserine receptor. J Cell Biol. 2001;155:501–504.
   PubMed Web of Science ®Google Scholar
• Cavicchioli R, Curmi PMG, Saunders N, et al. Pathogenic archaea: do they exist? Bioessays. 2003;25:1119–1128.
   PubMed Web of Science ®Google Scholar
• Gill EE, Brinkman FSL. The proportional lack of archaeal pathogens: do viruses/phages hold the key? Bioessays. 2011;33:248–254.
   PubMed Web of Science ®Google Scholar
• Krishnan L, Gurnani K, Dicaire CJ, et al. Rapid clonal expansion and prolonged maintenance of memory CD8+ T cells of the effector (CD44high CD62Llow) and central (CD44high CD62Lhigh) phenotype by an archaeosome adjuvant independent of TLR2. J Immunol. 2007;178:2396–2406.
   PubMed Web of Science ®Google Scholar
• Sprott GD, Côté J-P, Jarrell HC. Glycosidase-induced fusion of isoprenoid gentiobiosyl lipid membranes at acidic pH. Glycobiology. 2009;19:267–276.
   PubMed Web of Science ®Google Scholar
• Krishnan L, Dennis Sprott G. Archaeosomes as self-adjuvanting delivery systems for cancer vaccines. J Drug Target. 2003;11:515–524.
   PubMed Web of Science ®Google Scholar
• Conlan JW, Krishnan L, Willick GE, et al. Immunization of mice with lipopeptide antigens encapsulated in novel liposomes prepared from the polar lipids of various archaeobacteria elicits rapid and prolonged specific protective immunity against infection with the facultative intracellular pathogen. Vaccine. 2001;19:3509–3517.
   PubMed Web of Science ®Google Scholar
• Sprott GD, Dicaire CJ, Côté J-P, et al. Adjuvant potential of archaeal synthetic glycolipid mimetics critically depends on the glyco head group structure. Glycobiology. 2008;18:559–565.
   PubMed Web of Science ®Google Scholar
• Whitfield DM, Eichler EE, Sprott GD. Synthesis of archaeal glycolipid adjuvants-what is the optimum number of sugars? Carbohydr Res. 2008;343:2349–2360.
   PubMed Web of Science ®Google Scholar
• Sprott GD, Yeung A, Dicaire CJ, et al. Synthetic archaeosome vaccines containing triglycosylarchaeols can provide additive and long-lasting immune responses that are enhanced by archaetidylserine. Archaea. 2012;2012:513231.
   PubMed Web of Science ®Google Scholar
• Krishnan L, Deschatelets L, Stark FC, et al. Archaeosome adjuvant overcomes tolerance to tumor-associated melanoma antigens inducing protective CD8 + T cell responses. Clin Dev Immunol. 2010;2010:1–13.
   Google Scholar
• Harty JT, Badovinac VP. Shaping and reshaping CD8+ T-cell memory. Nat Rev Immunol. 2008;8:107–119.
   PubMed Web of Science ®Google Scholar
• Pamer EG. Immune responses to Listeria monocytogenes. Nat Rev Immunol. 2004;4:812–823.
   PubMed Web of Science ®Google Scholar
• Gregory SH, Liu CC. CD8+ T-cell-mediated response to Listeria monocytogenes taken up in the liver and replicating within hepatocytes. Immunol Rev. 2000;174:112–122.
   PubMed Web of Science ®Google Scholar
• Pamer EG, Harty JT, Bevan MJ. Precise prediction of a dominant class I MHC-restricted epitope of Listeria monocytogenes. Nature. 1991;353:852–855.
   PubMed Web of Science ®Google Scholar
• Ansari MA, Zubair S, Tufail S, et al. Ether lipid vesicle-based antigens impart protection against experimental listeriosis. Int J Nanomedicine. 2012;7:2433–2447.
   PubMedGoogle Scholar
• Higa LH, Corral RS, Morilla MJ, et al. Archaeosomes display immunoadjuvant potential for a vaccine against Chagas disease. Hum Vaccin Immunother. 2013;9:409–412.
   PubMed Web of Science ®Google Scholar
• Patel GB, Zhou H, Ponce A, et al. Mucosal and systemic immune responses by intranasal immunization using archaeal lipid-adjuvanted vaccines. Vaccine. 2007;25:8622–8636.
   PubMed Web of Science ®Google Scholar
• Patel GB, Ponce A, Zhou H, et al. Structural characterization of archaeal lipid mucosal vaccine adjuvant and delivery (AMVAD) formulations prepared by different protocols and their efficacy upon intranasal immunization of mice. J Liposome Res. 2008;18:127–143.
   PubMed Web of Science ®Google Scholar
• Patel GB, Zhou H, Ponce A, et al. Intranasal immunization with an archaeal lipid mucosal vaccine adjuvant and delivery formulation protects against a respiratory pathogen challenge. PLoS One. 2010;5:e15574.
   PubMed Web of Science ®Google Scholar
• Prausnitz MR, Langer R. Transdermal drug delivery. Nat Biotechnol. 2008;26:1261–1268.
   PubMed Web of Science ®Google Scholar
• Higa LH, Schilrreff P, Perez AP, et al. Ultradeformable archaeosomes as new topical adjuvants. Nanomedicine. 2012;8:1319–1328.
   PubMed Web of Science ®Google Scholar
• Sprott GD, Whitfield DM, Krishnan L Synthetic archaeal glycolipid adjuvants. US8936793 B2. 2015.
   Google Scholar
• Sprott GD, Krishnan L, Conlon JW, et al. Archaeosomes as adjuvants and carriers for acellular vaccines to induce cytotoxic t lymphocyte (CTL) responses. WO2001026683 A3. 2001.
   Google Scholar